Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma? - sprookjes - yvandenbroek - TriplyDB

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

http://www.wikidata.org/entity/Q47621525

about

NFKB1 and Cancer: Friend or Foe?Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications

P2860

Q58758440-7878A4A4-C6E5-4AD7-927A-424571A6AFF9 Q58760425-69E06933-5813-4C39-A083-F383BCC59C37

P2860

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

http://www.wikidata.org/entity/Q47621525

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

@en

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

@nl

type

label

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

@en

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

@nl

prefLabel

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

@en

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

@nl

P1433

Q47621525-CA8B9326-A0F4-4AC0-B40B-4C5B0FE4BC7B

P1476

Q47621525-28036E0D-CB2F-4B63-A91A-F8F555FB9151

P2093

Q47621525-14763BA6-D370-40BB-A7FB-065DAAF84092

Q47621525-2207007B-7FAF-44F5-815C-18586D200523

Q47621525-7F56E862-5247-46BE-B547-46629102AC5D

Q47621525-9C301FAC-133E-4AB9-B006-B27819EC7F76

Q47621525-AA06108D-2784-4BCD-82F2-7619951CDF5A

Q47621525-CAB31A19-DE04-4583-A6F1-4BA11FA19ADC

Q47621525-CB1B3B91-A907-4AD3-807D-C3F818874C9A

Q47621525-EC2BBDEB-E6D7-4FB5-BF09-A6461AD6B7C4

Q47621525-EE16DC06-B830-4D54-AF05-5EE068E061E5

P2860

Q47621525-0E2F7214-67C5-45F1-B2A2-2C03DAC54462

Q47621525-1304D7BD-165E-4893-92B3-D4CDDF71C524

Q47621525-162011A5-A585-4308-AFB1-08878B5DAAE0

Q47621525-2921E5B9-4D08-44FE-9CD6-2036E1B65BE2

Q47621525-2DE7300E-704C-4AD9-9E3E-1A136AC28156

Q47621525-2E224E43-73C4-4BDD-8222-B876FAF37B83

Q47621525-2FD42027-A921-4348-BFBA-0B422D51D858

Q47621525-35DBAFD4-B005-4390-AE1C-B6386273D316

Q47621525-3AD924CA-6C6F-44F7-8934-90C018FC098B

Q47621525-3FB0F4D3-B5F2-4BEB-88F5-93E407F72534

P2888

Q47621525-00675A99-A580-4817-9A7D-F1CCF087E647

P304

Q47621525-482872DA-0422-40E7-B942-389372CC20C2

P31

Q47621525-45170564-CD41-493B-9E18-FB3EC7DA00CD

P356

Q47621525-40E815AF-59E6-457C-A6C2-5A27489B9E95

P407

Q47621525-AC0E6EEA-79A5-4354-9200-EB8806DD96D1

P433

Q47621525-65DC150D-8EAA-4972-98B8-E00A4C07DDED

P478

Q47621525-001F55D0-1A50-4A75-A432-6ED7564A2BD0

P50

Q47621525-59BEC4A1-AC3F-4F88-8C48-59C712A238DB

Q47621525-DC23AD29-7A51-42D9-A89D-5C36072199AD

Q47621525-DE4F57A4-98CF-420F-B527-1A44D28EE8D6

P577

Q47621525-39675100-F837-440E-9F19-AB13FD05B54A

P698

Q47621525-EBF92F2C-67C2-4307-8504-6AE5849CE9A5

P932

Q47621525-77060DF2-082F-4307-B010-565582546C13

P356

P1433

British Journal of Cancer

P1476

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

@en

P2093

Anthony W H Chan

http://www.w3.org/2001/XMLSchema#string

Caroline L Wilson

http://www.w3.org/2001/XMLSchema#string

Derek A Mann

http://www.w3.org/2001/XMLSchema#string

Derek M Manas

http://www.w3.org/2001/XMLSchema#string

Helen L Reeves

http://www.w3.org/2001/XMLSchema#string

Jane Margetts

http://www.w3.org/2001/XMLSchema#string

K C Allen Chan

http://www.w3.org/2001/XMLSchema#string

Laura F Ogle

http://www.w3.org/2001/XMLSchema#string

Stephen L Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

The role of neutrophils in the development of liver diseases

Sorafenib in advanced hepatocellular carcinoma

Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.

P2888

P304

248-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2017.386

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Catherine E Willoughby

P577

2017-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29123264

http://www.w3.org/2001/XMLSchema#string

P932

5785742

http://www.w3.org/2001/XMLSchema#string